Deep dives on infectious disease diagnostics, molecular testing advances, AI in clinical science, regulatory updates, and global health — from our editorial team and invited contributors.
“` Top Infectious Diseases & Molecular Diagnostics Conferences In The UK In 2026 The UK has become one of the most active hubs for infectious diseases and molecular diagnostics conferences in 2026. UKHSA’s genomic surveillance infrastructure, NHS diagnostic networks, the London School of Hygiene and Tropical Medicine, and ongoing fallout…
Diagnostics IndustryInfectious disease diagnostics is one of the few areas of laboratory medicine where the commercial opportunity and the clinical urgency point in the same direction. Resistance is rising, pathogens keep emerging, and the tests that identify an infection quickly are the ones that determine whether treatment is targeted or guessed. That does not make it […]
Diagnostics IndustryMost of what is written about multiplex PCR testing explains primer design and reaction chemistry. That is not the decision anyone in a hospital is actually making. The decision is whether to buy a syndromic panel, for which patients, and whether the result justifies a cost that is often several times a targeted test. This […]
Diagnostics IndustryMost published material on PCR is written for the person receiving the result. This is written for the people who run it, buy it and sell it. PCR diagnostics is the method underneath a very large share of modern infectious disease testing, and it has been in routine clinical use for decades. What changed after […]
Diagnostics IndustryTuberculosis is curable, and has been for decades. It remains one of the world’s deadliest infectious diseases anyway, and the reason is rarely the drugs. It is that people are diagnosed late, or diagnosed without knowing which drugs will still work against the strain they are carrying. That makes TB a diagnostics problem before it […]
Diagnostics IndustryIf you manufacture in vitro diagnostics, the IVDR has probably already reshaped your product roadmap, your evidence budget and your launch timelines. If you are entering the European or UK market for the first time, it determines what you can sell and when. This guide sets out what the IVDR is, what changed from the […]
Diagnostics IndustryThe 105 hospitals in England that provide pathology services carry out around 1.12 billion tests a year. Almost none of those tests are visible to the patient, and most clinicians interact with the service only through a result on a screen. That invisibility is precisely why the field is poorly understood by the commercial teams […]
Academia and Hospital or Other End-User organisations attend FutureDx Summit 2026 free.
Complimentary passes are reserved for Academia and Hospital or Other End-User organisations. Solution Providers are not eligible for a complimentary pass. Register here.